BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37199610)

  • 1. Burkholderia contaminans Bacteriophage CSP3 Requires O-Antigen Polysaccharides for Infection.
    Stanton CR; Batinovic S; Petrovski S
    Microbiol Spectr; 2023 Jun; 11(3):e0533222. PubMed ID: 37199610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a PRD1-like phage uncovers the carriage of three putative conjugative plasmids in clinical Burkholderia contaminans.
    Stanton CR; Petrovski S; Batinovic S
    Res Microbiol; 2024; 175(5-6):104202. PubMed ID: 38582389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Interactions among
    Lauman P; Dennis JJ
    Microbiol Spectr; 2023 Jun; 11(3):e0443022. PubMed ID: 37195168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the Diversity of
    Nordstrom HR; Griffith MP; Rangachar Srinivasa V; Wallace NR; Li A; Cooper VS; Shields RK; Van Tyne D
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474392
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hassan AA; Coutinho CP; Sá-Correia I
    Front Cell Infect Microbiol; 2019; 9():273. PubMed ID: 31417878
    [No Abstract]   [Full Text] [Related]  

  • 7. The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections.
    Semler DD; Lynch KH; Dennis JJ
    Front Cell Infect Microbiol; 2011; 1():27. PubMed ID: 22919592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.
    Roszniowski B; Latka A; Maciejewska B; Vandenheuvel D; Olszak T; Briers Y; Holt GS; Valvano MA; Lavigne R; Smith DL; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2017 Feb; 101(3):1203-1216. PubMed ID: 27770178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Phage Therapy: Targeting the
    Lauman P; Dennis JJ
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage steering of
    Ruest MK; Supina BSI; Dennis JJ
    J Bacteriol; 2023 Oct; 205(10):e0019623. PubMed ID: 37791751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex.
    Kenna DT; Barcus VA; Langley RJ; Vandamme P; Govan JR
    FEMS Immunol Med Microbiol; 2003 Mar; 35(2):87-92. PubMed ID: 12628542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of bacteriophages of the Burkholderia cepacia complex.
    Seed KD; Dennis JJ
    FEMS Microbiol Lett; 2005 Oct; 251(2):273-80. PubMed ID: 16140471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
    Kamal F; Dennis JJ
    Appl Environ Microbiol; 2015 Feb; 81(3):1132-8. PubMed ID: 25452284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
    J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Milagro: a platform for engineering a broad host range virulent phage for
    Yao G; Le T; Korn AM; Peterson HN; Liu M; Gonzalez CF; Gill JJ
    J Virol; 2023 Nov; 97(11):e0085023. PubMed ID: 37943040
    [No Abstract]   [Full Text] [Related]  

  • 16. Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.
    Lynch KH; Dennis JJ
    Can J Microbiol; 2012 Mar; 58(3):221-35. PubMed ID: 22339239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
    Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L
    Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Isolation and Characterization of a Broad Host Range Bcep22-like Podovirus JC1.
    Davis CM; Ruest MK; Cole JH; Dennis JJ
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.
    Semler DD; Goudie AD; Finlay WH; Dennis JJ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4005-13. PubMed ID: 24798268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster of Burkholderia cepacia Complex Infections Associated With Extracorporeal Membrane Oxygenation Water Heater Devices.
    Rhee C; Baker MA; Tucker R; Vaidya V; Holtzman M; Seethala RR; Bentain-Melanson M; Lenox J; Smith AR; Boyer JC; Gassett A; Brigl M; Sater M; Huntley M; Woolley AE; Goldberg HJ; Reilly K; Resnick A; Pearson M; Klompas M
    Clin Infect Dis; 2022 Oct; 75(9):1610-1617. PubMed ID: 35271726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.